Any and all applications for which a foreign or domestic priority claim is identified in the Application Data Sheet as filed with the present application are hereby incorporated by reference under 37 CFR 1.57.
1. Field of the Inventions
The present inventions relate to apparatuses for treating sleep apnoea. For example, the present inventions can provide a nasal positive airway pressure device.
2. Description of the Related Art
Obstructive Sleep Apnoea (OSA) is a sleep disorder that affects up to at least 5% of the population in which muscles that normally hold the airway open relax and ultimately collapse, sealing the airway. The sleep pattern of an OSA sufferer is characterised by repeated sequences of snoring, breathing difficulty, lack of breathing, waking with a start and then returning to sleep. Often the sufferer is unaware of this pattern occurring. Sufferers of OSA usually experience daytime drowsiness and irritability due to a lack of good continuous sleep.
In an effort to treat OSA sufferers, a technique known as Continuous Positive Airway Pressure (CPAP) was devised. A CPAP device consists of a gases supply (or blower) with a conduit connected to supply pressurised gases to a patient, usually through a nasal mask. The pressurised air supplied to the patient effectively assists the muscles to keep the patient's airway open, eliminating the typical OSA sleep pattern.
The procedure for administering CPAP treatment has been well documented in both the technical and patent literature. Briefly stated, CPAP treatment acts as a pneumatic splint of the airway by the provision of a positive pressure, usually in the range 4 to 20 cm H.sub.2O. The air is supplied to the airway by a motor driven blower whose outlet passes via an air delivery hose to a nose (or nose and/or mouth) mask sealingly engaged to a patient's face by means of a harness or other headgear. An exhaust port is provided in the delivery tube proximate to the mask. More sophisticated forms of positive airway pressure devices, such as bi-level devices and auto-titrating devices, are described in U.S. Pat. No. 5,148,802 of Respironics, Inc. and U.S. Pat. No. 5,245,995 of Rescare Limited, respectively.
U.S. Pat. No. 5,477,852 of Airways Ltd, Inc. discloses a nasal positive airway pressure device that has a pair of nasal members each having a cannula tip to be inserted into the nares of the patient. Each cannula is tapered from a substantially circular cross-section outside the patient's nostril to a substantially oval cross-section at the tip inserted into the nostril. An inflatable cuff surrounds each cannula with the interior space of the cuff communicating with the lumen of the cannula through at least one aperture in the sidewall of the cannula. The nasal members are connected to one or more flexible hoses that, in turn, are connected to a source of positive air pressure. In use, positive air pressure is supplied to each cannula tip through the air hoses and nasal members. The positive air pressure inflates the cuffs to hold the nasal members in place and to effect treatment. The nasal device of U.S. Pat. No. 5,477,852 is attached to headgear that is located about a patient's head; this headgear could be considered by many patients as cumbersome and uncomfortable.
Conventional nasal masks used for administrating CPAP treatment are also considered uncomfortable and cumbersome, and prior art nasal masks and the like are noisy (due to air leaks). These disadvantages in many cases are a formidable obstacle to patient acceptance of such treatment. Therefore, a substantial number of patients either cannot tolerate treatment or choose to forego treatment. It is believed a substantial number of such patients could benefit from a nasal positive airway pressure apparatus that is more convenient to use and comfortable to wear, thereby resulting in increased treatment compliance.
As oxygen is supplied as a dry gas it is well known in the art to either heat and/or humidify gases before delivering them for breathing by a patient. In particular when delivering oxygen, or oxygen or air mixture, it has proven beneficial to humidify the gases first. In WO01/41854 of Vapotherm, Inc. a system is disclosed that allows the delivery of humidified oxygen through a nasal cannula. This system uses a narrow bore conduit and nasal cannula with a high resistance to gas flows, thereby requiring the oxygen be of a high pressure. Air, as well as oxygen can also be passed down the conduit and nasal cannula and it too must be of a high pressure. This system allows the delivery of high flows of oxygen enriched air to the patient, but is limited in the flows achievable due to the narrow bore of the cannula resulting in high resistance gas flow and excessive velocity and noise upon exiting the cannula. Furthermore, the narrowness of the nasal cannula in this system allows easy expiration of gases between the prongs and nares and therefore does not create any positive airway pressure.
Innomed Technologies, Inc. manufactures a nasal cannula device called the NASALAIRE™. In this device air or oxygen travels down a wide bore conduit to nasal cannula. The NASALAIRE™ creates a physical seal between the nares and itself, and relies on the absence of leaks around itself and the nares to deliver pressure supplied by a continuous positive airway pressure (CPAP) blower to the airway of the wearer.
It is an object of at least some of the present inventions to provide a breathing assistance apparatus which goes someway to overcoming the above mentioned disadvantages or which will at least provide the public a useful choice.
Accordingly in a first aspect the present inventions consists in a breathing assistance apparatus comprising:
nasal cannula, shaped to fit within a user's nares, and adapted to deliver said humidified gases to said user,
a pressurised source of gases,
transportation means adapted to, in use, be in fluid communication with said source of gases and said nasal cannula and adapted to in use convey said gases to said user,
wherein said nasal cannula including at least one prong allowing high flow delivery of said humidified gases and creating a positive airway pressure in said patient's airway, said at least one prong having an angled end, such that in use, gases flowing through said prong are directed to said user's nasal passages.
In a second aspect the present inventions consists in a breathing assistance apparatus comprising:
nasal cannula, shaped to fit within a user's nares,
a pressurised source of gases,
transportation means adapted to, in use, be in fluid communication with said source of gases and said nasal cannula and adapted to in use convey said gases to said user,
wherein said nasal cannula are adapted to deliver said humidified gases to said user, said nasal cannula including at least one prong allowing high flow delivery of said humidified gases and creating positive airway pressure in said patient's airway, said at least one prong having an end that is flared outwardly.
To those skilled in the art to which the inventions relate, many changes in construction and widely differing embodiments and applications of the invention will suggest themselves without departing from the scope of the inventions as defined in the appended claims. The disclosures and the descriptions herein are purely illustrative and are not intended to be in any sense limiting.
Preferred forms of the present inventions will now be described with reference to the accompanying drawings.
Whether used in a hospital environment or in a home environment, the nasal cannula of the present inventions will generally have associated three main pieces of apparatus. Firstly, an active humidifier, which that controls the temperature of a heater plate heating a body of water to achieve a desired temperature and humidity of the gases being humidified. Secondly, a transport conduit from the humidifier to the patient is also required, which is preferably heated to reduce condensation, or “rain out”. Thirdly, a cannula designed to fit into the nasal cavity and deliver humidified, pressurized gases. In particular, in one embodiment the nasal cannula of the present invention has two flared end prongs that seal within a patient's nares, although in some embodiments the cannula may have a single prong. The cannula prongs are shaped such that a step is created between them so that the prongs abut the user's nasal septum in use. Furthermore, the gripping action of the sides of the prongs to the user's septum in use prevents the prongs from dislodging from the user's nares. In another embodiment the prongs of the nasal cannula are angled toward one another as well as having an angled profile at the outlet of gases, such that gases flow from the prongs flows back into the nasal passage and is not forced up into the rest of the nasal cavity.
With reference to
The controller 9 receives input from sources such as user input means or dial 10 through which a user of the device may, for example, set a predetermined required value (preset value) of humidity or temperature of the gases supplied to patient 1. The controller may also receive input from other sources; for example, temperature and/or flow velocity sensors 11 and 12 through connector 13 and heater plate temperature sensor 14. In response to the user set humidity or temperature value input via dial 10 and the other inputs, controller 9 determines when (or to what level) to energise heater plate 7 to heat the water 6 within humidification chamber 5. A flow of gases (for example air) is provided to the chamber through inlet 16 from a gases supply means or blower 15. As the volume of water 6 within humidification chamber 5 is heated, water vapour begins to fill the volume of the chamber above the water's surface and is passed out of the humidification chamber 5 through outlet 4. Exhaled gases from the patient's mouth are passed directly to ambient surroundings in
The blower 15 is provided with variable pressure regulating means or a variable speed fan 20 which draws air or other gases through the blower inlet 17. The speed of the variable speed fan 20 is controlled by the electronic controller 18 (or alternatively the function of the controller 18 could carried out by the controller 9) in response to inputs from the controller 9 and a user set predetermined required value (preset value) of pressure or fan speed via the dial 19.
Flared Prong Nasal Cannula
A first embodiment of a nasal cannula of the present invention is shown in detail in
The prong part 21 has two nasal prongs 24, 25, each of which are substantially shaped to follow the contours of the human nares and in use are placed inside a user's nares. The prongs 24, 25 extend out from a hollow tubular body 26 that in use fits to the body part 22. Each of the prongs 24, 25 are integrally moulded with the tubular body 26 in a flexible plastics material or rubber, such as silicone, other thermoset elastomers or thermoplastic elastomers such as Kraton™. The prongs 24, 25 are substantially oval tubular members that allow for a passage of gases. In particular, as shown in
The prongs 24, 25 each include a step 33, 34 formed along their lengths. Each of the steps 33, 34 are formed on the prongs 24, 25 in an opposing manner such that in use, when the prongs are within a user's nares the steps 33, 34 abut the user's nasal septum and form a ledge that prevents dislodgement of the prongs. The prongs 24, 25 also have protrusions 35, 36 formed on their outer edges that abut the sides of the user's nares (opposite to the nasal septum). The protrusions 35, 36 assist in preventing the dislodgement of the prongs, especially if the user moves his or her head. The protrusions 35, 36 also maintain the prongs within the user's nares in a correct orientation such that in use gases flow through the prongs and directly up the user's nasal passages.
The body part 22 is a tubular passageway in which the prong part 21 is connected at one end and a ball joint 37 at the other end. The ball joint 37 extends from the connector 23 and slots into a complementary shaped (partial sphere) socket end 39. The body part 22 also has a number of apertures 38 formed in it, which act as a bias flow outlet vent. Therefore, any gases exhaled by the user through their nose will exit through the apertures 38.
The connector 23 is preferably connected to the inspiratory conduit 3 (see
Although a ball and socket joint, as described above, between the body part 22 and connector 23 is preferred other connections may be utilised, such as a flexible piece of silicone, or other appropriate connection. The connection between the cannula body and connector must be able to be flexed or rotated to allow for the inspiratory conduit 3 to be moved without causing the dislodgement of the nasal cannula 2 from the user's nares.
In the preferred form of the nasal cannula 2 of the present invention the body part 22 and connector 23 are preferably made from a hard or rigid plastics material, such as polypropylene, polycarbonate or acetyl. In other forms the body part 22 and connector 23 may be of different plastics materials to allow for increased slidability between these parts.
The prong part 21 may be supplied in various different sizes such that different sized user's may remove an existing prong part and simply attach a different sized flexible plastics prong part over the body part 22.
To provide additional comfort for the user or ensure the nasal cannula of the present invention do not fall from a user's nares, the nasal cannula may be used in combination with a headgear strap, which in one embodiment is a small flexible tube. For example,
The abovementioned embodiment of the nasal cannula 2 of the present invention is preferably a wide bore pronged cannula used for high flow conditions.
A second embodiment of the present invention is shown in
Furthermore, in this second embodiment the nasal cannula 42 is smaller and weighs less as it is only comprised of a prong body 45 and prongs 43, 44, where the body 45 is connected to a small tube that is formed with corrugations or bellows 48 that connect to an inspiratory tube or conduit 47 (similar to the inspiratory conduit 3 described above) that receives a supply of gases.
The corrugations of bellows 48 will bend or move when a weight or force is placed on the cannula, thereby preventing dislodgement of the cannula 42 from a user's face in use. In particular, the corrugations or bellows 48 prevent transferral of the torque onto the cannula 42 when a user moves his or her head.
The body 45 of the cannula 42 is provided with a number of apertures 46 that allows for gases exhaled by the users to be expelled into the ambient air.
The prong body and prongs of this embodiment of the cannula of the present invention are preferably formed a flexible plastics material or rubber, such as silicone, other thermoset elastomers or thermoplastic elastomers such as Kraton™.
A third embodiment of the nasal cannula of the present invention is shown in
Angled Prong Nasal Cannula
A fourth embodiment of the nasal cannula of the present invention is shown in
The prong part 61 preferably has two nasal prongs 64, 65, each of which are substantially shaped to follow the contours of the human nares and in use are placed inside a user's nares. In some forms a cannula with only one prong may be provided. The prongs 64, 65 extend out from a hollow tubular body 66 that in use fits to the body part 62, preferably about an extension 67 (as shown in the exploded view of the nasal cannula of
In particular, as shown in
In the preferred form the prongs 64, 65 have an angled and profiled end 76 (see
Each of the prongs 64, 65 has a flange 73, 74 disposed about its circumference. The flanges 73, 74 are at a position on the prongs 64, 65 such that the each of the flanges rests against the outside of each of the patient's nares. The flanges 73, 74 do not extend inside the nares, but rest at the entranceway of the user's nares, and preferably seal the nares. In some users the flanges 73, 74 may extend within the user's nares and provide sealing of the nares. The flanges 73, 74 are preferably thin flexible extensions that extend substantially completely around the circumference of the prongs 64, 65. The flanges 73, 74 are preferably substantially elliptical in shape with one side (for example, side 89, which in use will abut the nasal septum of a user) of the flange extending out from each prong further than the other side of each prong. There is a recessed area 88 on each of the prongs between the flange and the shaped ends of the prongs in which preferably in use the ends of a user's nares rest.
The body part 62 is a tubular passageway in which the prong part 61 is connected at one end and a ball joint 69 at the other end. The ball joint 69 extends from the connector 63 and slots into a complementary shaped (partial sphere) socket end 70 on the body part 62. The body part 62 may also have a plurality of apertures 71 formed in it, which acts as a bias flow outlet vent. Therefore, any gases exhaled by the user through their nose will exit through the apertures 71.
A shield 75 (illustrated by the dashed line in
In a sixth embodiment as shown in
Referring back to
In other forms of the present invention the ball joint connector 63 or the ball joint 69 may have formed in it a plurality of channels. One example of this is the embodiment of
In
It is preferred that there is a ball and socket joint, as described above, between the body part 62 and connector 63, although other connections may be utilised, such as a flexible piece of silicone, or other appropriate connection. The connection between the cannula body and connector must be able to be flexed or rotated to allow for the inspiratory conduit 3 to be moved without causing the dislodgement of the nasal cannula 60 from the user's nares.
In the preferred form of the nasal cannula 60 of the present invention the body part 62, connector 63, ball joint 69 and swivel connector 68 are preferably made from a hard or rigid plastics material, such as polypropylene, polycarbonate or acetyl. In other forms these may be of different plastics materials to allow for increased slidability between these parts.
The prong part 61 may be supplied in various different sizes such that different sized user's may remove an existing prong part and simply attach a different sized flexible plastics prong part over the body part 62.
To provide additional comfort for the user or ensure the nasal cannula of the present invention does not fall from a user's nares, the nasal cannula 60 is preferably used in combination with a headgear strap. The strap may be similar to that shown in
In other forms the ends of the headgear strap that attach to the cannula may attach to extensions (or loops) 41 on the body part 22 of the cannula shown in
Number | Date | Country | Kind |
---|---|---|---|
531332 | Feb 2004 | NZ | national |
534606 | Aug 2004 | NZ | national |
Number | Name | Date | Kind |
---|---|---|---|
301111 | Genese | Jul 1884 | A |
472238 | Van Orden | Apr 1892 | A |
577926 | Miller | Mar 1897 | A |
718470 | Jones | Jan 1903 | A |
751091 | Moran | Feb 1904 | A |
770013 | Linn | Sep 1904 | A |
1635545 | Drager | Jul 1927 | A |
2296150 | Dockson et al. | Sep 1942 | A |
2359506 | Battley et al. | Oct 1944 | A |
2388604 | Eisenbud | Nov 1945 | A |
2508050 | Valente | May 1950 | A |
2693800 | Caldwell | Nov 1954 | A |
2738788 | Matheson et al. | Mar 1956 | A |
2843121 | Hudson | Jul 1958 | A |
2859748 | Hudson | Nov 1958 | A |
3490452 | Greenfield | Jan 1970 | A |
3850171 | Ball et al. | Nov 1974 | A |
4090510 | Segersten | May 1978 | A |
D250047 | Lewis et al. | Oct 1978 | S |
D250131 | Lewis et al. | Oct 1978 | S |
D252322 | Johnson | Jul 1979 | S |
4201205 | Bartholomew | May 1980 | A |
4266540 | Panzik et al. | May 1981 | A |
4354488 | Bartos | Oct 1982 | A |
4367735 | Dali | Jan 1983 | A |
4437462 | Piljay | Mar 1984 | A |
D293613 | Wingler | Jan 1988 | S |
4753233 | Grimes | Jun 1988 | A |
4782832 | Trimble et al. | Nov 1988 | A |
4856508 | Tayebi | Aug 1989 | A |
4915105 | Lee | Apr 1990 | A |
4941467 | Takata | Jul 1990 | A |
D310431 | Bellm | Sep 1990 | S |
4971051 | Toffolon | Nov 1990 | A |
4986269 | Hakkinen | Jan 1991 | A |
5016625 | Hsu et al. | May 1991 | A |
5042478 | Kopala et al. | Aug 1991 | A |
D320677 | Kumagai et al. | Oct 1991 | S |
D321419 | Wallace | Nov 1991 | S |
5065756 | Rapoport | Nov 1991 | A |
5094236 | Tayebi | Mar 1992 | A |
5113857 | Dickerman et al. | May 1992 | A |
5148802 | Sanders et al. | Sep 1992 | A |
5231979 | Rose et al. | Aug 1993 | A |
5245995 | Sullivan et al. | Sep 1993 | A |
D340317 | Cole | Oct 1993 | S |
5269296 | Landis | Dec 1993 | A |
D354128 | Rinehart | Jan 1995 | S |
D355484 | Rinehart | Feb 1995 | S |
5477852 | Landis et al. | Dec 1995 | A |
5533506 | Wood | Jul 1996 | A |
5551419 | Froehlich et al. | Sep 1996 | A |
5595174 | Gwaltney | Jan 1997 | A |
5601078 | Schaller et al. | Feb 1997 | A |
D378610 | Reischel et al. | Mar 1997 | S |
5657752 | Landis et al. | Aug 1997 | A |
5724965 | Handke et al. | Mar 1998 | A |
5752510 | Goldstein | May 1998 | A |
5884624 | Barnett et al. | Mar 1999 | A |
5921239 | McCall et al. | Jul 1999 | A |
6017315 | Starr et al. | Jan 2000 | A |
6019101 | Cotner et al. | Feb 2000 | A |
6050260 | Daniell et al. | Apr 2000 | A |
6119694 | Correa et al. | Sep 2000 | A |
6192886 | Rudolph | Feb 2001 | B1 |
D440302 | Wolfe | Apr 2001 | S |
6298850 | Argraves | Oct 2001 | B1 |
6347631 | Hansen et al. | Feb 2002 | B1 |
D455891 | Biedrzycki | Apr 2002 | S |
6418928 | Bordewick et al. | Jul 2002 | B1 |
6431172 | Bordewick | Aug 2002 | B1 |
6435181 | Jones, Jr. et al. | Aug 2002 | B1 |
6439234 | Curti et al. | Aug 2002 | B1 |
6478026 | Wood | Nov 2002 | B1 |
6491034 | Gunaratnam et al. | Dec 2002 | B1 |
6561188 | Ellis | May 2003 | B1 |
6561191 | Kwok | May 2003 | B1 |
6581594 | Drew et al. | Jun 2003 | B1 |
6581601 | Ziaee | Jun 2003 | B2 |
6588424 | Bardel | Jul 2003 | B2 |
6631718 | Lovell | Oct 2003 | B1 |
6637434 | Noble | Oct 2003 | B2 |
6644315 | Ziaee | Nov 2003 | B2 |
6651658 | Hill et al. | Nov 2003 | B1 |
6659102 | Sico | Dec 2003 | B1 |
6662803 | Gradon et al. | Dec 2003 | B2 |
6679257 | Robertson et al. | Jan 2004 | B1 |
6679265 | Strickland et al. | Jan 2004 | B2 |
6851425 | Jaffre et al. | Feb 2005 | B2 |
6892729 | Smith et al. | May 2005 | B2 |
6907882 | Ging et al. | Jun 2005 | B2 |
6951218 | Gradon et al. | Oct 2005 | B2 |
7004165 | Salcido | Feb 2006 | B1 |
D520140 | Chaggares | May 2006 | S |
D526094 | Chen | Aug 2006 | S |
7096864 | Mayer et al. | Aug 2006 | B1 |
7201169 | Wilkie | Apr 2007 | B2 |
7207333 | Tohara | Apr 2007 | B2 |
7210481 | Lovell et | May 2007 | B1 |
7219669 | Lovell et al. | May 2007 | B1 |
7318437 | Gunaratnam et al. | Jan 2008 | B2 |
7353827 | Geist | Apr 2008 | B2 |
7896003 | Matula et al. | Mar 2011 | B2 |
8042539 | Chandran et al. | Oct 2011 | B2 |
8443807 | McAuley et al. | May 2013 | B2 |
D686313 | Matula et al. | Jul 2013 | S |
8479741 | McAuley et al. | Jul 2013 | B2 |
8783257 | McAuley et al. | Jul 2014 | B2 |
20020046755 | Voss | Apr 2002 | A1 |
20020053347 | Ziaee | May 2002 | A1 |
20020059935 | Wood | May 2002 | A1 |
20020096178 | Ziaee | Jul 2002 | A1 |
20030005933 | Izuchukwu | Jan 2003 | A1 |
20030079749 | Strickland et al. | May 2003 | A1 |
20030164170 | Drew et al. | Sep 2003 | A1 |
20030172936 | Wilkie et al. | Sep 2003 | A1 |
20030196656 | Moore | Oct 2003 | A1 |
20030196659 | Gradon et al. | Oct 2003 | A1 |
20030196664 | Jacobson | Oct 2003 | A1 |
20030200970 | Stenzler | Oct 2003 | A1 |
20040067333 | Amarasinghe | Apr 2004 | A1 |
20040211427 | Jones et al. | Oct 2004 | A1 |
20040226566 | Gunaratnam et al. | Nov 2004 | A1 |
20050011524 | Thomlinson | Jan 2005 | A1 |
20050028822 | Sleeper et al. | Feb 2005 | A1 |
20050076913 | Ho et al. | Apr 2005 | A1 |
20050150497 | Eifler et al. | Jul 2005 | A1 |
20050205096 | Matula et al. | Sep 2005 | A1 |
20050235999 | Wood et al. | Oct 2005 | A1 |
20060060200 | Ho et al. | Mar 2006 | A1 |
20060107958 | Sleeper | May 2006 | A1 |
20060124131 | Chandran | Jun 2006 | A1 |
20060137690 | Gunaratnam et al. | Jun 2006 | A1 |
20060174887 | Chandran et al. | Aug 2006 | A1 |
20060196511 | Lau et al. | Sep 2006 | A1 |
20060237018 | McAuley et al. | Oct 2006 | A1 |
20070089749 | Ho et al. | Apr 2007 | A1 |
20070125385 | Ho et al. | Jun 2007 | A1 |
20070125387 | Zollinger et al. | Jun 2007 | A1 |
20070137653 | Wood | Jun 2007 | A1 |
20070163600 | Hoffman | Jul 2007 | A1 |
20070295335 | Nashed | Dec 2007 | A1 |
20080041388 | McAuley et al. | Feb 2008 | A1 |
20080047560 | Veliss et al. | Feb 2008 | A1 |
20080060648 | Thornton et al. | Mar 2008 | A1 |
20080060657 | McAuley et al. | Mar 2008 | A1 |
20080099024 | Gunaratnam et al. | May 2008 | A1 |
20080196728 | Ho | Aug 2008 | A1 |
20080264422 | Fishman | Oct 2008 | A1 |
20090044808 | Guney et al. | Feb 2009 | A1 |
20090120442 | Ho | May 2009 | A1 |
20100307502 | Rummery et al. | Dec 2010 | A1 |
20100313891 | Veliss et al. | Dec 2010 | A1 |
20110308520 | McAuley et al. | Dec 2011 | A1 |
20120125339 | Ho et al. | May 2012 | A1 |
20120132209 | Rummery et al. | May 2012 | A1 |
20150013678 | McAuley | Jan 2015 | A1 |
20150297855 | McAuley et al. | Oct 2015 | A1 |
20160038705 | McAuley et al. | Feb 2016 | A1 |
20160038706 | McAuley et al. | Feb 2016 | A1 |
20160038707 | Allan et al. | Feb 2016 | A1 |
Number | Date | Country |
---|---|---|
131 16 62 | Dec 1992 | CA |
217 253 8 | Jul 1994 | CN |
1784250 | Jun 2006 | CN |
1901961 | Jan 2007 | CN |
1988930 | Jun 2007 | CN |
101214402 | Jul 2008 | CN |
101541380 | Sep 2009 | CN |
0747078 | Dec 1996 | EP |
2 130 563 | Dec 2009 | EP |
1646910 | Aug 2015 | EP |
2658725 | Aug 1991 | FR |
2749176 | Dec 1997 | FR |
190 224 431 | Dec 1902 | GB |
880 824 | Oct 1961 | GB |
1 467 828 | Mar 1977 | GB |
H09-010311 | Jan 1997 | JP |
2005-529687 | Oct 2005 | JP |
2007-516750 | Jun 2007 | JP |
2007-527271 | Sep 2007 | JP |
WO9818514 | May 1998 | WO |
WO 9904842 | Feb 1999 | WO |
WO9958181 | Nov 1999 | WO |
WO 0069497 | Nov 2000 | WO |
WO 0074758 | Dec 2000 | WO |
WO0141854 | Jun 2001 | WO |
WO 0197892 | Dec 2001 | WO |
WO02074372 | Sep 2002 | WO |
WO 2004041341 | May 2004 | WO |
WO 2004073778 | Sep 2004 | WO |
WO 2005021075 | Mar 2005 | WO |
WO 2005051468 | Jun 2005 | WO |
WO 2005086946 | Sep 2005 | WO |
WO 2007022562 | Mar 2007 | WO |
WO 2007041786 | Apr 2007 | WO |
WO 2007147088 | Dec 2007 | WO |
WO 2008007985 | Jan 2008 | WO |
WO 2008070929 | Jun 2008 | WO |
WO 2008106716 | Sep 2008 | WO |
WO2008148086 | Dec 2008 | WO |
WO 2009052560 | Apr 2009 | WO |
WO 2009059353 | May 2009 | WO |
WO 2009092057 | Jul 2009 | WO |
WO 2009139647 | Nov 2009 | WO |
Entry |
---|
International Preliminary Report on Patentability (IPRP), International Application No. PCT/NZ2009/000219, mailed Apr. 12, 2011, 9 pages. |
International Search Report, International Application No. PCT/NZ2009/000219, mailed Feb. 2, 2010, 3 pages. |
English Translation of Chinese Examination Report; Application No. 2007800266164; 5 pages. |
English Translation of First Office Action for Chinese Application No. 201210080441.8 dated Mar. 24, 2014, in 4 pages. |
Examination Report; Australian Application No. 2007273324; dated May 22, 2012; 3 pages. |
International Search Report for International Application No. PCT/NZ2007/000185, dated Oct. 31, 2007, in 3 pages. |
Second Chinese Office Action for Chinese Patent Application No. 201210080441.8 dated Dec. 1, 2014 in 11 pages (with English translation). |
Australian Examination Report for Patent Application No. 2012265597 dated Dec. 19, 2013, in 5 pages. |
Canadian Examination Report for Application No. 2655839 dated Oct. 4, 2013, in 2 pages. |
English Translation of Chinese Examination Report; Chinese Application No. 2007800266164; 5 pages. |
International Search Report; PCT/NZ2009/000072; dated Jul. 28, 2009; 3 pages. |
UK Search and Examination Report; Mar. 14, 2013; Application No. GB1210075.6; 2 pages. |
UK Examination Report; dated May 9, 2013; Application No. GB1119385.1; 4 pages. |
Australian Examination Report; dated Mar. 4, 2014; Application No. 2010246985; 5 pages. |
English Translation of JP Examination Report; dated Feb. 10, 2014; Application No. 2012-510418; 4 pages. |
Chinese Examination Report; dated Mar. 27, 2014; Chinese Application No. 201080028029.0; 16 pages. |
GB Combined Search and Examination Report; dated May 7, 2014; Application No. GB1406402.6; 6 pages. |
GB Combined Search and Examination Report; dated May 7, 2014; Application No. GB1406401.8; 4 pages. |
JP Examination Report, Application No. 2012-538784; 3 pages. |
Australian Examination Report; dated Aug. 14, 2015; Application No. 2015202814; 8 pages. |
Chinese Examination Report; dated Jul. 17, 2015; Application No. 201080061122.1; 10 pages. |
Chinese Examination Report; dated Sep. 14, 2015; Application No. 201080028029.0; 3 pages. |
European Extended Search Report; dated Sep. 4, 2015; Application No. 10830251.4; 7 pages. |
European Extended Search Report; dated Sep. 8, 2015; Application No. 10774623.2; 7 pages. |
Japanese Examination Report; dated Jul. 22, 2015; Application No. 2015-098324; 8 pages. |
Japanese Examination Report; dated Aug. 5, 2015; Application No. 2012-538784; 8 pages. |
Australian Examination Report; dated Jan. 9, 2015; Application No. 2010241390; 4 pages. |
English Translation of Chinese Examination Report; dated Sep. 3, 2014; Application No. 201080061122.1; 9 pages. |
Second Chinese Office Action; dated Jan. 19, 2015; Application No. 201080028029.0; 16 pages. |
EPO Search Report; dated Apr. 2, 2014; Application No. 09819444.2; 8 pages. |
Number | Date | Country | |
---|---|---|---|
20150374946 A1 | Dec 2015 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14333134 | Jul 2014 | US |
Child | 14846226 | US | |
Parent | 10598026 | US | |
Child | 14333134 | US |